Clin2
NCT06702696Possibly a fitRecruiting

Study on aronia berries for COPD inflammation

COPD (Chronic Obstructive Pulmonary Disease)

Part of Lungs & breathing clinical trials.

This trial tests whether eating aronia berries (black chokeberries) can help reduce inflammation in people with COPD. It may offer a natural way to manage COPD symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
50 years to 80 years
Study type
Interventional

Who can take part

  • You are between 50 and 80 years old
  • You have been diagnosed with COPD
  • You are not a smoker
  • You are willing to eat aronia berries provided by the study
  • You have not had a bronchial tube or valve surgery in the last 2 years
  • You do not have other inflammatory diseases, chronic infections, kidney disease, cancer, or certain blood disorders

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06664957Not yet recruiting
Vitamin C for slowing COPD progression

This study tests whether vitamin C, an antioxidant, can help slow the progression of COPD and improve prognosis. If you qualify, you may take vitamin C and have your lung health monitored over time.

NCT07339280Enrolling by invitation
Probiotics for COPD: symptoms, lungs, and inflammation

This study tests whether taking a probiotic can improve symptoms, lung function, and inflammation in people with COPD. It is for adults with stable COPD who have not had a flare-up or treatment change in the last two months.

Karlovac
NCT05297279Recruiting
Omega-3 diet program for people with COPD

This trial tests whether increasing omega-3 (from diet and/or supplements) helps people with COPD. It enrolls people with low omega-3 intake and asks them to follow a specific dietary plan during the study.

Baltimore, Maryland
NCT07646587Recruiting· Phase 2
Safety Study of WIN378 for Moderate-Severe COPD

This study tests a new drug called WIN378 in people with moderate-to-severe COPD (chronic lung disease). It will check if the drug is safe and how the body processes it, which may help improve breathing and reduce flare-ups.

Los Angeles, California
NCT07376161Enrolling by invitation
Inflammation and oxidative stress study in stable COPD

This study looks at how inflammation and oxidative stress affect COPD. It tests whether a pulmonary rehabilitation program helps reduce these factors in people with stable COPD who are former smokers.

Istanbul, Kadikoy
NCT07868211Not yet recruiting
Fiber supplement to lower inflammation in COPD

This study tests whether taking a daily fiber supplement can reduce inflammation in people with COPD (a lung disease that makes breathing harder) and improve their overall health. If you have stable COPD and get a certain amount of fiber from your diet, you may be able to join.

Belo Horizonte, Minas Gerais

Hear when a new COPD (Chronic Obstructive Pulmonary Disease) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.